Medicines Top Source of Kids' Poisonings
... most common reasons included relaxation, feeling good or getting high, experimentation and then pain relief. Students used drugs such as hydrocodone, oxycodone
(Oxycontin), hydromorphone, meperidine, morphine and codeine without a prescription, the researchers found.
The dangers of misused cold medications...
DURECT Corporation Announces Second Quarter 2009 Financial
...rking closely with the FDA toward
approval of the product.
REMOXY, an investigational drug, is a long acting oral formulation of
intended to treat moderate to severe pain. Based on DURECT's
ORADUR(R) technology, which is covered by issued patents and pending
Narconon Trois-Rivieres Cites 'Hillbilly Heroin' as Canadian Drug Addiction Crisis
... chronic illnesses and severe to mild pain relief. oxycodone
is found in many different pain medications, but i... other chemicals. For example, Percocet has 5mg of oxycodone
in it combined with acetaminophen, which is the co... drug found in Tylenol. In OxyContin there is only oxycodone
in it, in its purest form. OxyContin tablets can c...
King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan
...nues to anticipate the resubmission could occur mid-year 2010.
About REMOXY (R)
REMOXY(R), an investigational drug, is a unique, long-acting oxycodone
formulation for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY(R) was accepted ...
REMOXY(R) NDA Update
...of the product.
REMOXY, based on DURECT's ORADUR(TM) technology, is an investigational drug that is a unique, controlled release formulation of oxycodone
for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY was accepted by the FDA and ...
If 2 Painkillers Are Banned, What Next?
...ately, can be used safely."
Narcotic painkillers such as hydrocodone and oxycodone
run the risk of being abused. "We want to get tighter control," Fishman sai...e pain relief from just one of the components in Percocet, he explained.
alone is "probably just as effective for pain," Shurman said. "Tylenol [ace...
NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain
...t efficacy in pain relief following orthopedic surgery and significant reduction in composite incidence of nausea and/or vomiting compared to 10-mg of oxycodone
IMPORTANT SAFETY INFORMATION
Like other drugs with mu-opioid agonist activity, NUCYNTA(TM) is contraindicated in patients with signific...
KV Pharmaceutical Company, Purdue Pharma L.P. Settle OxyContin(R) Dispute
...eceives limited license rights to all strengths of oxycodone
ST. LOUIS, June 9 ...with an abuse liability similar to morphine.
can be abused in a manner similar to other opioid ...blets are a controlled-release oral formulation of oxycodone
hydrochloride indicated for the management of mode...
Pain Medicine Experts Recommend Monitoring, Education for All Opioid Medicines
On May 27-28, 2009, the FDA will hold public hearings on its proposed REMS for extended release pain medications such as morphine, oxycodone
and methadone. AAPM members have committed to working with the FDA to ensure that REMS for pain medicine takes the needs of the medical community and...
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Roxicodone(R) Tablets
...es, Ltd. (NYSE Amex: CPD ) has recently launched oxycodone
hydrochloride tablets on behalf of Sun Pharmaceuti...ion (ANDA) for generic Roxicodone(R) tablets.
hydrochloride tablets are an immediate-release oral formulation of oxycodone
hydrochloride indicated for the management of mode...
Oxycodone in Medical Technology
New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Many strong acting pain
medications have bothersome side effects. These can include nausea and
vomiting with short-term use, and constipation with longer, chronic use.
Such symptoms can lead patients to discontinue treatment, adding additional
Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
MELBOURNE, Australia, Sept. 17 /PRNewswire-FirstCall/ -- Phosphagenics
Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced that, following
successful preclinical studies, it plans to undertake a Phase 1 transdermal
oxycodone clinical trial aimed at providing chronic pain sufferers with ...
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
...following submission of their response.
About Acurox Tablets
Acurox is a patented, orally administered, immediate release tablet containing oxycodone
HCl as its sole active analgesic ingredient with a proposed indication for the relief of moderate-to-severe pain. Acurox utilizes Acura's proprietary...
King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
...) Tablets are a unique composition of short-acting oxycodone
HCl, niacin and functional inactive ingredients in... with Aversion(R) Technology, are a composition of oxycodone
HCl, niacin, and other inactive ingredients. The n...lerability of Niacin 30 mg and 60 mg Combined With oxycodone
HCl 5 mg Versus...
New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
...nt reduction in nausea and/or vomiting compared to oxycodone
Results from the new Phase 3 study of t...d the same percentage of improvement with 10-mg of oxycodone
IR. Results were similar for patients who experie...he tapentadol IR 75-mg group and 64 percent in the oxycodone
IR 10-mg group.
The most common treatment-eme...
QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
... IR Provides Better Tolerability Than Morphine and oxycodone
SYDNEY, Australia and BEDMINSTER, N.J.,...cts. These results confirm 12mg/8mg morphine plus oxycodone
combination as the preferred dose for optimal effi...ive patients greater tolerability than morphine or oxycodone
alone," said Dr. John Holaday, Managing Director a...
Premier Research Announces Milestone New Drug Application
... our people," commented Dr. Troy McCall, Chief Operating Officer.
Acurox(R), a patented, orally administered, immediate release tablet containing oxycodone
HCl as its sole active analgesic ingredient, has a proposed indication for the relief of moderate to severe pain. Acurox(R) utilizes Acura Pharmaceut...
Advances in Science and Treatment of Pain Presented at 25th Annual American Academy of Pain Medicine Meeting January 28 - 31, 2009
Tramadol Outcomes, Poster 197
Safety, Tolerability and Effectiveness of Duloxetine for
Fibromyalgia, Poster 204
Effects of Oral oxycodone
in Recreational Drug Users, Poster 211
Evaluation of High Dose Opioids in Chronic Pain Patients, Poster 220
Long Term Opioid Therapy May Suppr...
REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
...rights for this drug candidate to King Pharmaceuticals
(NYSE: KG ). REMOXY, an investigational drug, is a unique, abuse-resistant,
controlled release oxycodone
for moderate-to-severe chronic pain.
About ORADUR(TM) Technology
ORADUR is a proprietary technology designed to transform short-acting
QRxPharma Releases Additional Phase 3 Data for Q8003IR 'Dual Opioid' Pain Therapy
... John Holaday, Managing Director and
Chief Executive Officer, QRxPharma. "These data confirm that our patented
dual opioid combination of morphine and oxycodone
effects on pain relief and is able to achieve equal or better analgesia at
materially lower doses than the active opioid comparat...
Oxycodone in Biological News
A new target for painkillers
Common pain medicines like aspirin, ibuprofen and acetaminophen often fail to relieve neuropathic pain. Morphine-like opiods such as oxycodone
sometimes are used, but can cause constipation, nausea and a spaced-out feeling.
Anticonvulsant drugs for epilepsy sometime are used to reduce t...
Oxycodone in Biological Technology
Phosphagenics Announces Successful Phase 1 Transdermal Oxycodone Clinical Trial Results
MELBOURNE, Australia, Dec. 17 /PRNewswire-FirstCall/ -- Phosphagenics
Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today
announced positive results of its Phase 1 clinical trial that showed its
delivery technology, TPM, delivered leading pain-relief drug oxycodone
through the s...
New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
New Approach in the Development of Opioid-Based Pain Management Therapy Improves Bowel Function
CAMBRIDGE, England, September 26 /PRNewswire/ -- The oral
prolonged-release (PR) oxycodone
/ naloxone combination tablet reduces
opioid-induced bowel dysfunction in patients w...
IntelliPharmaCeutics Announces Successful Completion of a Pilot Clinical Trial for its Abuse and Alcohol Resistant Sustained Release Oxycodone
TORONTO, March 27 /PRNewswire/ - IntelliPharmaCeutics Ltd. (Delaware)
is pleased to announce significant results from a recently completed pilot
clinical trial for its new abuse-resistant, alcohol-resistant once-a-day
formulation by its operating company IntelliPharmaCeutics
QRxPharma Initiates Comparative Phase 2 Proof-of-Concept Study for MoxDuo(TM) IV Pain Therapy
...te that the Company's MoxDuo(TM) IR oral formulation consistently yields superior pain relief with a lower frequency of side effects than morphine and oxycodone
alone. We believe our intravenous formulation will demonstrate similar benefits as seen with orally administered MoxDuo(TM) IR," said Dr. Holaday. "...
King and Pain Therapeutics Announce REMOXY(R) NDA Update
...o working closely with the FDA toward approval of the product.
About REMOXY (R)
REMOXY, an investigational drug, is a unique, long-acting oxycodone
formulation for moderate-to-severe chronic pain designed to reduce potential risks of unintended use. In mid-2008, an NDA for REMOXY was accepted by ...
Phosphagenics Announces Completion of Transdermal Patch Prototypes
... - oxycodone
Successfully Delivered into the Bloodstream
-...es Sustained Release and Increased Blood Levels of oxycodone
MELBOURNE, Australia, May 29 /PRNewswire-Firs...ystems developed by Phosphagenics, the delivery of oxycodone
was significantly increased when compared to the C...
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
... date, data indicate that QRxPharma's patented combination of morphine plus oxycodone
works synergistically to increase analgesia while diminishing the usual sid... (bunionectomy) pain that compares MoxDuo(TM) IR against morphine alone and oxycodone
alone, and a placebo-controlled study of the effectiveness of MoxDuo(TM) IR...
ETHEX Corporation Issues Nationwide Voluntary Recall of Products
...ating Tablets, 8mg (58177-364-22 & 364-56)
HCl Capsules, 5mg (58177-041-04 & 041-11)
HCl IR Tablets, 10mg (58177-461-04)
HCl IR Tablets, 15mg, (58177-445-04)
QRxPharma Initiates Comparative Study for MoxDuoIR(TM) Dual-Opioid(TM) Pain Therapy
...against equivalent analgesic doses of morphine and oxycodone
alone for the treatment of acute moderate to sever...ared to equivalent analgesic doses of morphine and oxycodone
alone," said Dr. John Holaday, Managing Director a...(TM) efficacy and safety to corresponding doses of oxycodone
and morphine in patients experiencing moderate to ...
Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
...e licenses limited sales of some generic oxycodone
STAMFORD, Conn., Sept. 2 /PRNewswire/ ...of 10 mg, 20 mg, 40
mg, and 80 mg extended-release oxycodone
In the most recent decision in the liti...nce
with an abuse liability similar to morphine.
can be abused in a manner similar to other opioid ...
Oxycodone in Biological Definition
...r euphoric effects
Opiates refined from the opium poppy
Synthetic and semi-synthetic opioids
(sold under the brand name Oxycontin, and contained in Percocet )